Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
India GlycolsBOM:500201 +0.88%66 Days Inventory is 133.89 as of Mar. 2026, which is 1% below its 10-year median of 134.90. GuruFocus rates BOM:500201 with a GF Score™ of 66/100 and a GF Value™ of ₹758.64 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,541 Chemicals companies, India Glycols ranks worse than 80.34% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). India Glycols's Average Total Inventories for the
three
months ended in Mar. 2026 was ₹8,906 Mil. India Glycols's Cost of Goods Sold for the
three
months ended in Mar. 2026 was ₹6,070 Mil.
Hence, India Glycols's Days Inventory for the
three
months ended in Mar. 2026 was 133.89.
The historical rank and industry rank for India Glycols's Days Inventory or its related term are showing as below:
BOM:500201'
s Days Inventory Range Over the Past 10 Years
Min: 85.21 Med: 134.9 Max: 172.59
Current: 143.74
During the past 13 years, India Glycols's highest Days Inventory was 172.59. The lowest was 85.21. And the median was 134.90.
BOM:500201's Days Inventory is ranked worse than 80.34% of 1541
companies
in the Chemicals industry
Industry Median: 80.15
vs BOM:500201: 143.74
India Glycols's Days Inventory
declined
from Mar. 2025 (200.12) to Mar. 2026 (133.89).
Inventory Turnover measures how fast the company turns over its inventory within a year.
India Glycols's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.68.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
India Glycols's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.91.
India Glycols (BOM:500201) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
India Glycols's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
India Glycols's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
India Glycols Days Inventory Related Terms
India Glycols Days Inventory Historical Data
* Premium members only.
The historical data trend for India Glycols's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, India Glycols's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
India Glycols Days Inventory vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, India Glycols's Days Inventory distribution charts can be found below:
* The bar in red indicates where India Glycols's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
India Glycols (BOM:500201) has a Days Inventory of 133.89 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on India Glycols and its competitors. This is near median its historical median of 134.90. Over the past decade, India Glycols' Days Inventory has ranged from 85.21 to 172.59. According to the industry distribution chart, India Glycols ranks #1238 out of 1541 companies in the Chemicals industry, placing it in the top 80.3%.
Is India Glycols' Days Inventory too high?
India Glycols' current Days Inventory of 133.89 is near median its 10-year median of 134.90. Over the past 10 years, this metric has ranged from a low of 85.21 to a high of 172.59. The Chemicals industry median Days Inventory is 80.15. India Glycols' value of 133.89 is 67% above this industry median. Based on the distribution chart, India Glycols ranks #1238 out of 1541 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, India Glycols has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does India Glycols' Days Inventory compare to DOW?
According to the Chemicals industry distribution chart, India Glycols ranks #1238 out of 1541 companies for Days Inventory. This places India Glycols in the lower half of its industry. The industry median Days Inventory is 80.15. India Glycols' value of 133.89 is 67% above this benchmark. Historically, India Glycols' own Days Inventory has ranged from 85.21 to 172.59 over the past decade. While the company's 10-year median is 134.90 vs. the industry median of 80.15, India Glycols has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Chemicals company?
The median Days Inventory among Chemicals companies is 80.15, based on 1,541 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. India Glycols's current Days Inventory of 133.89 is 67% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on India Glycols and its competitors. For the Chemicals industry, the median Days Inventory is 80.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. India Glycols's current Days Inventory is 133.89, which is near median its own 10-year median of 134.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is India Glycols stock overvalued right now?
Based on GuruFocus' analysis, India Glycols (BOM:500201) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹758.64, compared to a current price of ₹1,153.15 — trading 52% above its estimated fair value. The current Days Inventory is 133.89, which is near median its 10-year median of 134.90 and 67% above the Chemicals industry median of 80.15. India Glycols' overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For India Glycols (BOM:500201), the current Days Inventory is 133.89 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is India Glycols (BOM:500201) Overvalued in 2026?
Based on GuruFocus' analysis, India Glycols stock appears to be overvalued.
The current stock price of ₹1,153.15 is trading 52% above its estimated GF Value™ of ₹758.64.
GuruFocus considers India Glycols to be Significantly Overvalued.
Key valuation signals for BOM:500201:
Days Inventory: 133.89 (near median its 10-year median of 134.90)
GF Value™: ₹758.64 vs. price of ₹1,153.15 (52% above fair value)
Industry Position: 67% above the Chemicals median (#1238 of 1541)
No single metric tells the full story. See the BOM:500201 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
India Glycols Ltd is engaged in the manufacture of Bio-Based Specialities and Performance Chemicals, such as green technology-based bulk products, natural gums, and industrial gases; Potable Spirits, and Ennature Biopharma. The company operates through industries of Pharma & Healthcare, Oil & Gas, Textile, Food Ingredients, Automotive, Packaging, Personal Care, Potable Spirits, and Industrial and Manufacturing. Its operating segments are Bio-based Specialities and Performance Chemicals comprise Glycols, Specialty Chemicals, Natural Gum & other related goods, etc; Potable Spirits comprises the manufacture and sale of Ethyl Alcohol (Potable); Ennature Biopharma comprises the manufacture and sale of Nutraceutical Products; and Bio-fuel comprises Ethanol, DDGS & DWGS.
66GF Score
Get the complete analysis for BOM:500201
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:500201 has been successfully added to your 
